Safety and immunogenicity of the group B streptococcus vaccine AlpN in a placebo-controlled double-blind phase 1 trial

por Gonzalez-Miro, Majela, Pawlowski, Andrzej, Lehtonen, Janne, Cao, Duojia, Larsson, Sara, Darsley, Michael, Kitson, Geoff, Fischer, Per B., Johansson-Lindbom, Bengt
Publicado 2023

A group B Streptococcus alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains

por Pawlowski, Andrzej, Lannergård, Jonas, Gonzalez-Miro, Majela, Cao, Duojia, Larsson, Sara, Persson, Jenny J., Kitson, Geoff, Darsley, Michael, Rom, Ane Lilleøre, Hedegaard, Morten, Fischer, Per B., Johansson-Lindbom, Bengt
Publicado 2022